MSD (Merck Sharp & Dohme, Lda) and Logifarma agreed on the renewal and strengthening of the partnership for logistics and distribution for the period of 5 years.
This decision comes at the culmination of a rigorous process of analysis to the pharmaceutical logistics market, which was performed by MSD, and as a result the selection and bet on Logifarma services, until 2021. This represents the strengthening of a long partnership between the two companies which has started in 2001.
The high levels of service and quality, diversity and flexibility of the service portfolio, the focus on technological innovation and continuous improvement and adaptability to market needs, were factors, which combined with competitive costs allowed to MSD renew and strengthen the trust that 15 years ago were deposited in Logifarma operation.
According to Thomas Chaine: Associate Director, Integrated Logistics Procurement for EMEA: “Logifarma confirmed that they are the right choice for MSD now and for the future. Their professionalism, Flexibility, customer oriented approach and of course excellent operational and quality standards were all elements that convinced us in our decision. I am proud of what MSD and Logifarma accomplished together in the past 15 years and exited of what is yet to come from our relationship.”
Considering the leading position that Merck holds in the global pharmaceutical market, and the high quality standards which features in the selection of its partners, the choice of Logifarma is a source of pride for the entire team, it also represents a confirmation of Logifarma status as a reference in the logistics operator market in Portugal.